Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study

Z. Bakouny, C. Labaki, S. Bhalla, A. L. Schmidt, J. A. Steinharter, J. Cocco, D. A. Tremblay, M. M. Awad, A. Kessler, R. I. Haddad, M. Evans, F. Busser, M. Wotman, C. R. Curran, B. S. Zimmerman, G. Bouchard, T. Jun, P. V. Nuzzo, Q. Qin, L. HirschJ. Feld, K. M. Kelleher, D. Seidman, H. Huang, H. M. Anderson-Keightly, T. El Zarif, S. Abou Alaiwi, C. Champagne, T. D. Rosenbloom, P. S. Stewart, B. E. Johnson, Q. Trinh, S. M. Tolaney, M. D. Galsky, T. K. Choueiri, D. B. Doroshow

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study'. Together they form a unique fingerprint.

Medicine & Life Sciences